MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dopaminergic medication effect on speech in Parkinson’s disease: A kinematic study

T.E. Tong, M.L. Ng, N. Yan (Hong Kong, Hong Kong)

Meeting: 2016 International Congress

Abstract Number: 1858

Keywords: Dopaminergics, Dysarthria

Session Information

Date: Thursday, June 23, 2016

Session Title: Parkinson's disease: Clinical trials, pharmacology and treatment

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To investigate the effect of levodopa on articulatory movement during Cantonese plosive production in individuals with Parkinson’s disease (PD) by comparing kinematic parameters before and after medication.

Background: Levodopa-based dopaminergic medication for PD was proven effective in treating movement problems. However, the literature sees contradictory findings regarding it effects on PD speech problems. As over 80% of patients with PD suffer from hypokinetic dysarthria with slurred speech and distorted consonant productions, management for PD speech is as important as other motor functioning. Previous perceptual and acoustic studies of PD speech mostly involved heterogeneous population and speech tasks which complicated data interpretation. The lack of kinematic data also limited our understanding of articulation errors and medication effects. Electromagnetic articulography (EMA) enabled the examination of articulatory patterns and the kinematic data provided important information about levodopa effect on early PD speech in the present study.

Methods: Five PD participants with mean age 62.4 ± 9.6 years were recruited in the study. Inclusion criteria included comparable type of prescription, dosage of medication, onset year of PD, HY stage and UPDRS scores. Speech stimuli used included disyllabic words, sentences and Chinese passage. The EMA system (AG500) was used for data collection. Three sensor coils were attached on upper lip (UL), lower lip (LL) and jaw (J), with four reference coils for calibrating of the movements of articulators. To establish “off-state”, Core Assessment Program for Intracerebral Transplantation (CAPIT) protocol was followed as PD participants took no PD medications for 12 hours before the experiment. Subsequently, recording for “on-state” was done after 1.5 hour of medication intake.

Results: Preliminary kinematic results were comparable across the 5 participants with regard to the medication effect. Movements of UL, LL and J were found different before and after medication. All articulators displayed more timely and coordinated movements with reduced peak velocity, increased time-to-peak-velocity and increased range of movement.

Conclusions: The present kinematic findings suggested a positive effect of levodopa medication that appeared to facilitate initiation of articulatory movements and utilization the speech effort in terms of coordination and range of lip movements during speech.

To cite this abstract in AMA style:

T.E. Tong, M.L. Ng, N. Yan. Dopaminergic medication effect on speech in Parkinson’s disease: A kinematic study [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/dopaminergic-medication-effect-on-speech-in-parkinsons-disease-a-kinematic-study/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dopaminergic-medication-effect-on-speech-in-parkinsons-disease-a-kinematic-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley